Premium
Assessment of the impact of dissemination of genetically improved Abbassa Nile tilapia strain (GIANT‐G9) versus commercial strains in some Egyptian governorates
Author(s) -
Ibrahim Nabil Ahmad,
Mohamed NasrAllah Ahmed,
CharoKarisa Harrison
Publication year - 2019
Publication title -
aquaculture research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.646
H-Index - 89
eISSN - 1365-2109
pISSN - 1355-557X
DOI - 10.1111/are.14249
Subject(s) - broodstock , biology , nile tilapia , veterinary medicine , tilapia , fish <actinopterygii> , strain (injury) , fishery , aquaculture , zoology , oreochromis , medicine , anatomy
WorldFish initiated a selective breeding program in Abbassa—Egypt to develop and produce the genetically improved Nile tilapia strain known as “Genetically Improved Abbassa Nile tilapia (GIANT)”, adopting the same technology used for the Genetically Improved Farmed Tilapia (GIFT), in Asia. WorldFish provided the Ninth Generation (G9) broodstock of the GIANT to 11 Broodstock Multiplication Centers (BMC’s) in five governorates; these centres then disseminated improved mixed‐sex fry to 160 tilapia hatcheries which supplied all‐male fry to 1,500 fish farms in 2017. We present results of an impact assessment of the G9 of GIANT in 83 of these fish farms in four Egyptian governorates (Kafr El‐Sheikh, Fayoum, Behera and Alexandria). Results indicate that the use of GIANT in all governorates achieved significantly higher (18.8%) fish yields (12.3%–26.4%) and 15.7% lower FCR (feed conversion ratio), reflecting a positive impact on their net profits compared with those who used commercial strains. Overall, fish farmers who stocked GIANT had significantly higher average fish sales (5,567 US$/ha) than those who stocked non‐improved commercial strains (5,192 US$/ha) in all governorates. However, when comparing within governorates, the difference was significant only in Fayoum and Alexandria noting a mixed performance of the GIANT strain. The mixed performance indicates that some hatcheries may have crossed the different strains, which lowered the performance differences. To get an objective analysis of the performance of the GIANT, it is recommended that similar assessment be undertaken with new generations of the strain supported by on‐farm performance trials.